VideoRSVCOVID-19Oral Antivirals for COVID-19: How to Best Make Use of Their Therapeutic Effects | Giovanni Di Perri, MD, PhDView Video
VideoRSVCOVID-19Oral Antivirals for COVID-19: Drug-Drug Interactions as a Manageable Risk | David Burger, PharmD, PhDView Video
VideoRSVCOVID-19Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience - Part 1 | Catia Marzolini, PharmD, PhDView Video
VideoRSVCOVID-19Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience – Part 2 | Fiona Marra, MPharm, MScView Video
